Chemoinformaics analysis of O-Cymene
Molecular Weight | 134.222 | nRot | 1 |
Heavy Atom Molecular Weight | 120.11 | nRig | 6 |
Exact Molecular Weight | 134.11 | nRing | 1 |
Solubility: LogS | -3.653 | nHRing | 0 |
Solubility: LogP | 3.838 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 0 | APOL | 26.0351 |
nHD | 0 | BPOL | 14.0449 |
QED | 0.553 |
Synth | 1.396 |
Natural Product Likeliness | -0.658 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.004 |
Pgp-sub | 0.016 |
HIA | 0.005 |
CACO-2 | -4.307 |
MDCK | 0.0000229 |
BBB | 0.72 |
PPB | 0.94931 |
VDSS | 2.566 |
FU | 0.0583002 |
CYP1A2-inh | 0.931 |
CYP1A2-sub | 0.934 |
CYP2c19-inh | 0.69 |
CYP2c19-sub | 0.904 |
CYP2c9-inh | 0.406 |
CYP2c9-sub | 0.492 |
CYP2d6-inh | 0.422 |
CYP2d6-sub | 0.795 |
CYP3a4-inh | 0.117 |
CYP3a4-sub | 0.488 |
CL | 6.759 |
T12 | 0.356 |
hERG | 0.016 |
Ames | 0.032 |
ROA | 0.082 |
SkinSen | 0.132 |
Carcinogencity | 0.456 |
EI | 0.994 |
Respiratory | 0.035 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.918617 |